Erbitux News
Most Popular Erbitux Story
Alex Denner - The 25 most influential people in biopharma today
Good cop, bad cop Alex DennerHedge fund operator Carl Icahn may have received most of the credit, and certainly the lion's share of the cash, created by his high-profile biotech raiding parties. But Read more...
Latest Headlines
- February 7, 2012
- December 17, 2008
- September 12, 2008
- August 28, 2008
- June 3, 2008
- April 21, 2008
- October 12, 2007
- October 3, 2007
- September 13, 2007
- September 11, 2007
- August 10, 2007
- August 10, 2007
- July 12, 2007
- January 9, 2007
- December 18, 2006
- November 5, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
